Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21237227 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 18908)

Indicates status has not been verified in more than two years